Connor, Clark & Lunn Investment Management (CC&L)
NAGE

Connor, Clark & Lunn Investment Management (CC&L)’s Niagen Bioscience NAGE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$11.9M Buy
2025
Q1 		$5.14M Buy
2024
Q4 		$2.69M Buy
2024
Q3 		$639K Buy
2024
Q2 		$431K Buy
2024
Q1 		$463K Buy
2023
Q4 		$167K Buy
2023
Q3 		$121K Buy
2023
Q2 		$58.7K Buy